Drug intelligence / Profile preview

Haloeye Hydra PF

Development stage: Unknown
Lead developer: Eyekare Kilitch
Modality: Small Molecules
Administration: Ophthalmic

Overview

**Haloeye Hydra PF** is a preservative-free ophthalmic lubricant product developed by Eyekare Kilitch for dry eye disease. Each solution contains polyethylene glycol 400 0.4% w/v and propylene glycol 0.3% w/v. The formulation functions as an artificial-tear lubricant, hydrating and coating the ocular surface to reduce friction and provide temporary relief of dry-eye-associated irritation and discomfort. ([eyekarekilitch.com](https://eyekarekilitch.com/product/polyethylene-glycol-400-propylene-glycol-eye-drops/))

Brand names: Haloeye Hydra PF
Other names: polyethylene glycol 400 + propylene glycol preservative-free eye drops

Beyond the preview

Go deeper on Haloeye Hydra PF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haloeye Hydra PF.

Explore the full profile